History of infertility and risk of type 2 diabetes mellitus: a prospective cohort study

Diabetologia

Volumn 58, Issue 4, 2015, Pages 707-715

  Tobias, Deirdre K ^a,b   Gaskins, Audrey J ^b   Missmer, Stacey A ^a,b   Hu, Frank B ^a,b   Manson, JoAnn E ^a,b   Buck Louis, Germaine M ^c   Zhang, Cuilin ^c   Chavarro, Jorge E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Epidemiology; Fertility; Gestational diabetes; Infertility; Life course epidemiology; Ovulatory disorders; Prospective cohort; Reproductive health; Type 2 diabetes

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BIENNIAL QUESTIONNAIRE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOMETRIOSIS; FAMILY HISTORY; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MARRIAGE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL CONTRACEPTIVE USE; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; UTERINE CERVIX DISEASE; UTERINE CERVIX MUCUS; UTERINE TUBE; DIABETES MELLITUS, TYPE 2; FERTILITY; HEALTH SURVEY; INCIDENCE; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; QUESTIONNAIRE; TIME; UNITED STATES; YOUNG ADULT;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FERTILITY; HEALTH SURVEYS; HUMANS; INCIDENCE; INFERTILITY, FEMALE; INFERTILITY, MALE; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84925517353     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3493-z     Document Type: Article

References (40)

1. Buck Louis GM, Sundaram R, Schisterman EF et al (2012) Heavy metals and couple fecundity, the LIFE Study. Chemosphere 87:1201–1207
2. Buck Louis GM, Schisterman EF, Sweeney AM et al (2011) Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development—the LIFE Study. Paediatr Perinat Epidemiol 25:413–424
3. Wise LA, Rothman KJ, Mikkelsen EM, Sorensen HT, Riis A, Hatch EE (2010) An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod 25:253–264
4. Hull MG, Glazener CM, Kelly NJ et al (1985) Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 291:1693–1697
5. Lim SS, Norman RJ, Davies MJ, Moran LJ (2013) The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 14:95–109
6. Bhathena RK (2011) Insulin resistance and the long-term consequences of polycystic ovary syndrome. J Obstet Gynaecol 31:105–110
7. Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M (2014) Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol 30:397–402
8. Celik C, Tasdemir N, Abali R, Bastu E, Yilmaz M (2014) Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil Steril 101:1123–1128
9. Solomon CG, Willett WC, Carey VJ et al (1997) A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078–1083
10. Wallace WH, Kelsey TW (2010) Human ovarian reserve from conception to the menopause. PLoS One 5:e8772
11. Rich-Edwards JW, Goldman MB, Willett WC et al (1994) Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 171:171–177
12. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ (2004) Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 160:784–796
13. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057
14. (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
15. Manson JE, Rimm EB, Stampfer MJ et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778
16. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466–473
17. Willett W (1998) Nutritional epidemiology. Oxford University Press, New York
18. Chiuve SE, Fung TT, Rimm EB et al (2012) Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 142:1009–1018
19. Wolf AM, Hunter DJ, Colditz GA et al (1994) Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23:991–999
20. Elbers CC, Onland-Moret NC, Eijkemans MJ, Wijmenga C, Grobbee DE, van der Schouw YT (2011) Low fertility and the risk of type 2 diabetes in women. Hum Reprod 26:3472–3478
21. Hanley AJ, McKeown-Eyssen G, Harris SB et al (2002) Association of parity with risk of type 2 diabetes and related metabolic disorders. Diabetes Care 25:690–695
22. Kritz-Silverstein D, Barrett-Connor E, Wingard DL (1989) The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med 321:1214–1219
23. Mueller NT, Mueller NJ, Odegaard AO et al (2013) Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG 120:1483–1489
24. Liu B, Jorm L, Banks E (2010) Parity, breastfeeding, and the subsequent risk of maternal type 2 diabetes. Diabetes Care 33:1239–1241
25. Manson JE, Rimm EB, Colditz GA et al (1992) Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med 93:13–18
26. Gunderson EP, Lewis CE, Tsai AL et al (2007) A 20 year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes 56:2990–2996
27. Tobias DK, Chavarro JE, Williams MA et al (2013) History of infertility and risk of gestational diabetes mellitus: a prospective analysis of 40,773 pregnancies. Am J Epidemiol 178:1219–1225
28. Huang G, Coviello A (2012) Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 19:512–519
29. Randeva HS, Tan BK, Weickert MO et al (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 33:812–841
30. Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288–1299
31. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, Issue 2, Art. no.: CD003053. doi:10.1002/14651858.CD003053.pub4
32. Galazis N, Galazi M, Atiomo W (2011) d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review. Gynecol Endocrinol 27:256–262
33. Sonmez AS, Yasar L, Savan K et al (2005) Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 20:175–179
34. Penna IA, Canella PR, Reis RM, Silva de Sa MF, Ferriani RA (2005) Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study. Hum Reprod 20:2396–2401
35. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876–1880
36. Solomon CG, Hu FB, Dunaif A et al (2001) Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286:2421–2426
37. Kodaman PH, Arici A, Seli E (2004) Evidence-based diagnosis and management of tubal factor infertility. Curr Opin Obstet Gynecol 16:221–229
38. Sir-Petermann T, Marquez L, Carcamo M et al (2010) Effects of birth weight on anti-mullerian hormone serum concentrations in infant girls. J Clin Endocrinol Metab 95:903–910
39. Robker RL, Wu LL, Yang X (2011) Inflammatory pathways linking obesity and ovarian dysfunction. J Reprod Immunol 88:142–148
40. Tersigni C, Di Nicuolo F, D’Ippolito S, Veglia M, Castellucci M, Di Simone N (2011) Adipokines: new emerging roles in fertility and reproduction. Obstet Gynecol Surv 66:47–63